Jan 18 FDA's new expedited drug program raises legal questions and concerns By Matthew Perrone, Associated Press The FDA commissioner's effort to drastically shorten the review of drugs favored by President Donald Trump's administration is causing alarm across the agency. Continue reading
Jan 11 Watch 5:15 Investigation raises concerns about lack of FDA quality testing for generic drugs By John Yang, Andrew Corkery By some estimates, about 90% of prescriptions in the U.S. are filled with generic drugs. The Food and Drug Administration says that all agency-approved generic drugs “have the same high quality” as brand-name drugs, but a ProPublica investigation found that… Continue watching
Dec 01 New lens approved by FDA promises to slow nearsightedness in children By Matthew Perrone, Associated Press The lenses use concentric rings to refocus light, potentially preventing severe eye issues like cataracts and retinal detachment. Continue reading
Nov 23 What to know about menopause hormone therapy after FDA removed 'black box' warnings By Grace Abels, PolitiFact The FDA removed safety warnings from several hormone drugs used to treat menopause symptoms. Here’s what you need to know about these treatments before your next doctor's appointment. Continue reading
Nov 10 Watch 8:47 FDA head explains decision to drop 'black box' warnings from menopause hormone treatment By Ali Rogin, Courtney Norris The FDA announced it would begin asking drug companies to remove so-called “black box” warnings for hormones prescribed to treat symptoms of menopause. The FDA says the warning has dissuaded generations of women from taking advantage of the medication that… Continue watching
Nov 09 What to know about the FDA's recall of the blood pressure drug prazosin By C. Michael White, The Conversation A generic blood pressure drug called prazosin, made by Teva Pharmaceuticals, is being recalled by the Food and Drug Administration because it contains elevated levels of cancer-causing chemicals called nitrosamines. Continue reading
Nov 03 Top FDA drug regulator resigns after officials probe 'serious concerns' about his conduct By Matthew Perrone, Associated Press The head of the Food and Drug Administration’s drug center abruptly resigned Sunday amid concerns about his personal conduct. Continue reading
Sep 22 Tylenol maker says it 'strongly disagrees' with Trump's claims about acetaminophen By Associated Press Kenvue said in a statement that “sound science clearly shows that taking acetaminophen does not cause autism.”… Continue reading
Sep 22 OB-GYN group calls Trump's remarks on acetaminophen 'irresponsible' By Associated Press The president of the American College of Obstetricians and Gynecologists said Monday that suggestions that Tylenol use in pregnancy causes autism are “irresponsible when considering the harmful and confusing message they send to pregnant patients.”… Continue reading
Sep 05 Why did the EU ban gel nail polish? 3 things to know By Genesis Magpayo Many people love gel nail polish for its durability and shiny gloss, but a new ban in Europe may have left mani-pedi devotees with some not-so-pretty concerns. Continue reading